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The ultraviolet spectrophotometry analysis for quantitative assay of drugs is a method accurate, sensitive, selective and 
reproductive with the advantage of being a simple and less expensive method. In this study, a derivative ultraviolet 
spectrophotometric method was developed for simultaneous determination of pyrazinamide (PYZ) and rifampicin (RIF). 
The spectrophotometric method was evaluated according to validation guidelines for specificity, linearity, limits of 
detection and quantification, precision, accuracy and robustness. The first-derivative spectra were obtained and by the zero-
crossing point, the wavelength 247 nm and 365 nm were selected for PYZ and RIF quantification, respectively. No 
interference from cubosome excipients was detected in the proposed method. The results demonstrated linearity in a range 
of 4.0 – 12.0 µg/mL with an adequate correlation coefficient for both drugs. The intra and inter-day precision results (RSD 
< 5%) indicated the reproducibility of the method. The accuracy data showed satisfactory results (RSD < 5%) from 
recovery test. In addition, the robustness results showed that the PYZ and RIF content were unaffected by the solvent 
alteration of methanol to methanol:water (99:1, v/v). The derivative ultraviolet spectrophotometric method proved to be an 
excellent strategy for simultaneous determination of PYZ and RIF. 
 





World Health Organization recognizes four drugs for 
tuberculosis diseases: pyrazinamide (PYZ), rifampicin 
(RIF), isoniazid and ethambutol (1). Pyrazinamide 
(pyrazine-2-carboxamide; Figure 1) is classified as a 
crystalline white or almost white powder, slightly soluble in 
water and ethanol (2). This drug is an analog of 
nicotinamide with bactericidal property (3). The 
mechanism of action of PYZ is unknown and experimental 
evidence suggests that bactericidal action is dependent of 
the pyrazinamidase enzyme from Mycobacterium 
tuberculosis (4). Once PYZ is converted into pyrazinoic 
acid by bacterial pyrazinamidase, the high concentrations of 
pyrazinoic acid in the bacterial cytoplasm decrease the 
intracellular pH causing inactivation of vital enzymes, 
resulting in the death of the bacillus (5).  
 
 








1(29),2,4,9,19,21,25,27-octaen-13-yl acetate; Figure 1) is a 
red to orange odorless powder, very slightly soluble in 
water and ethanol; and soluble in methanol (2). RIF is a 
semi-synthetic antibiotic derived from rifamycin B, 
produced by strains of Amycolatopsis rifamycinica (6). It 
presents a broad spectrum bactericidal action, inhibiting the 
activity of the DNA-dependent RNA polymerase enzyme, 
which prevents the synthesis of messenger RNA (mRNA) 
and protein by the bacillus, causing cell death (7). 
In order to prevent the emergence of bacterial resistance, 
PYZ and RIF are used in combination (1,3). In addition to 
the pharmacotechnical challenges for the preparation of 
formulations containing this association, it is necessary to 
develop new analytical methods for the simultaneous 
determination of drugs. Several published studies used 
different analytical techniques for the determination of 
antituberculosis drugs alone and in combination, including 
High Performance Liquid Chromatography (HPLC) with 
UV detector (8,9), High Performance Thin Layer 
Chromatography (HPTLC) (10), Ultra-high Performance 
Liquid Chromatography (UHPLC) with UV detector 
(11,12), Fourier Transform Infrared (FTIR) spectroscopy in 
combination with multivariate calibration of partial least 
square (13) and UV spectrophotometry (14). Due to the 
absence of an analytical method for the simultaneous 
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determination of PYZ and RIF by derivative 
spectrophotometric method and considering the importance 
of analytical methods for the simultaneous determination of 
drugs, this study aims to develop and validate a simple and 
rapid derivative spectrophotometric method for the 
determination of PYZ and RIF in cubosome formulation. 
 




The PYZ and RIF (pharmaceutical grade) were gently 
donated by Fundação para o Remédio Popular (Brazil) and 
Farmanguinhos (Brazil), respectively. The phytantriol 
(3,7,11,15-tetramethyl-1,2,3-hexadecanetriol, 96.9%) and 
poloxamer 407 (PEO98-PPO67-PEO98, MW 12,500 
g/mol) were purchased from Alianza (Brazil) and Via 
Farma (Brazil), respectively. Methanol analytical grade was 
supplied from J.T. Barker and was used to prepare all 




The validation of the PYZ and RIF quantification by 
ultraviolet spectrophotometry method started with 
preliminary tests (data not showed). Different solvents were 
tested, such as acetonitrile, phosphate buffer, water, ethanol 
and methanol. The methanol was selected since it had a 
great capability to dissolve the phytantriol, the main 




The PYZ and RIF were quantified by spectrophotometric 
method carried out on LAMBDA 265 UV/Vis 
Spectrophotometer (PerkinElmer, USA) connected to UV 
LAB 4.0.0 software. The absorbance was determined 
within the range of 200 to 400 nm using matched 1 cm 
quartz cells. Measurements were performed using a 
standard solution of PYZ and RIF in methanol in order to 




The spectrophotometric method for simultaneous 
determination of PYZ and RIF was validated for specificity, 
linearity, limits of detection (LOD) and quantification 
(LOQ), precision, accuracy and robustness according to the 
International Conference on Harmonization (ICH) 
guidelines Q2 (R1) for the validation of analytical methods 
(15) and to RDC nº 166 of July 24, 2017 (16).  
 
Preparation of standard solutions 
 
For the preparation of the standard solution, PYZ (5 mg) 
and RIF (5 mg) were dissolved, separately, in methanol (10 




Preparation of unloaded cubosomes 
 
Cubosomes were prepared as described previously (17) 
with some modifications. Phytantriol (750 mg), poloxamer 
407 (187.5 mg) and deionized water (30 mL) were 
homogenized for 25 min by a 500 W ultrasonic processor 
(Ecosonics, Brazil) at 99% of amplitude and with a 13 mm 
diameter probe. The final volume was corrected to 30 mL 




Specificity was evaluated by analyzing solutions of 
unloaded cubosomes. The system response was determined 
through the presence of overlaps of unloaded cubosomes 




The linearity experiments were conducted from a standard 
solution of PYZ and RIF. Aliquots of standard solution 
were diluted in methanol to obtain the final concentrations 
of 4.0, 6.0, 8.0, 10.0 and 12.0 µg/mL of PYZ and RIF. All 
solutions were prepared in triplicate and analyzed on three 
different days. Calibration curves (concentration vs 
absorbance) were plotted, and the equation of the line was 
determined through the linear regression, using the method 
of least squares. The analysis of variance (ANOVA) was 
also calculated for the statistical parameters. The linearity 
was expressed as the correlation coefficients. 
 
Limits of detection and quantitation 
  
The LOD and LOQ were estimated using the standard 
deviation of the value of the intercept with the Y axis and 
slope of three calibration curves. The LOD and LOQ were 





For repeatability (intra-day precision) experiment, six 
solutions containing a combination of PYZ and RIF at 
central point of the standard curves (concentration of 8.0 
µg/mL of each drug) were evaluated on the same day under 
the same experimental conditions. The intermediate 
precision (inter-day precision) of the method was assessed 
with PYZ (8.0 µg/mL) and RIF (8.0 µg/mL) solution and 
performed on three different days. The experimental results 




The accuracy experiments were determined by applying the 
method to quantify PYZ and RIF in the presence of the 
unloaded cubosome. Unloaded cubosomes were spiked 
with amount of PYZ and RIF at concentrations of 4.0, 8.0 
and 12.0 µg/mL of each drug. The analyses were performed 
in triplicates. Accuracy was expressed as percentage of 
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The robustness was determined by small variation in the 
established analytical condition. Samples of PYZ (8.0 
µg/mL) and RIF (8.0 µg/mL) prepared with methanol:water 
(99:1, v/v) were utilized to conducted the test. The 
experimental results were expressed as the RSD values.  
 
Results and Discussion 
 
Validation of the quantification method 
 
The spectrophotometry analysis for determination of drugs 
is a method accurate, sensitive, selective, reproductive and 
proved to be a less expensive alternative when compared to 
the HPLC method. However, analysis of drug mixtures by 
ultraviolet-visible spectrophotometry is often compromised 
due to the overlap of the electronic transition bands. As seen 
in Figure 2, the zero-order spectra of PYZ and RIF showed 
an overlapping, making the detection and quantification of 
drugs unfeasible. The zero-order spectra of PYZ and RIF 
were processed to obtain first-derivative spectra. By 
overlapping spectra of first-derivatives, it is possible to 
individualize the constituents and even eliminate the 
interference of one component on the other. The spectra of 
the first-derivative of PYZ and RIF were superimposed and 
showed that at wavelength 247 nm there is the annulment 
of the spectrum of the drug RIF as well as at wavelength 
365 nm, the annulment of PYZ occurs (Figure 3). 
 
 
Figure 2. Zero-order absorption spectra of PYZ (8.0 µg/mL) and 
RIF (8.0 µg/mL) obtained in methanol.  
 
 
Figure 3. Absorption spectra of the first-derivative spectra of PYZ 




The interference of the unloaded cubosome at the PYZ and 
RIF measurement was demonstrated in the specificity test. 
As clearly seen in the first-derivative spectrum of unloaded 
cubosome (Figure 4), a minimum absorption of 0.0002 at 
247 nm and 0.0001 at 365 nm was observed. These results 
are in agreement with previous studies (18,19), which 
observed that the first-derivative spectrophotometric 
method was able to eliminate the interference from 
excipients. The proposed analytical method is able to 
quantify these specific drugs in the presence of a complex 
matrix, such cubosomes, that contain the inputs phytantriol 
and poloxamer 407. 
 
 
Figure 4. Absorption spectra of the first-derivative of unloaded 
cubosome, standard solution of PYZ and RIF and unloaded 




The results from linearity test are summarized in Table 1. 
The least square regression showed excellent correlation 
between the PYZ concentration and the peak amplitude 
(247 nm) in the range of 4.0 and 12.0 µg/mL with r value 
of 0.999. Similarly correlation was observed for the RIF 
concentration and peak amplitude at 365 nm (r=0.998). 
Statistical analysis by ANOVA confirmed a linear 
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regression for PYZ (Fcalculated = 608.19 > Ftabulated = 4.96; 
p=0.05) and RIF (Fcalculated = 573.97 > Ftabulated = 4.96; 
p=0.05) and also shows that there is no deviation from 
linearity for PYZ (Fcalculated = 0.20 < Ftabulated = 3.71; p=0.05) 
and RIF (Fcalculated = 3.65 < Ftabulated = 3.71; p=0.05).  
 
Table 1. Linearity results obtained from standard curve of first-





Linear range 4.0 – 12.0 µg/mL 4.0 – 12.0 µg/mL 
Regression 
equation 





Limits of detection and quantitation 
 
The calculated LOD for PYZ and RIF was 0.87 µg/mL and 
0.82 µg/mL, respectively, which demonstrated a great 
sensitivity to detect the drugs. The LOQ was estimated at 
2.89 µg/mL for PYZ and 2.73 µg/mL for RIF. The results 
show that the proposed method allowed detection and 
quantification of low drug concentration, indicating that the 




The repeatability (intra-day precision) and intermediate 
precision (inter-day precision) data expressed as RSD are 
showed in Table 2. The first-derivative spectrophotometric 
method for simultaneous quantification of PYZ and RIF 
demonstrated an adequate repeatability. The RSD for both 
drugs were less than 5.0%, which are in accordance with the 
guidelines. Similar results were observed in intermediate 
precision (inter-day precision) with acceptable RSD range 
(≤ 5.0%) which represents an agreement between the results 
obtained when performing the analysis in the same 
laboratory but on different days.  
 
Table 2. Repeatability and intermediate precision values of first-
















































The method accuracy was studied at three different levels 
(low, medium and high concentration) and by adding 
unloaded cubosomes. The drugs recovery experiments were 
carried, and the results are shown at Table 3. 
 
Table 3. Recovery results of pyrazinamide and rifampicin in the 













PYZª 4.00 4.67 116.67  2.47 
RIFª 4.00 3.78 94.44 2.55 
2 
PYZª 8.00 8.21 102.63 3.40 
RIFª 8.00 7.72 96.53 2.49 
3 
PYZª 12.00 12.40 103.33 1.40 
RIFª 12.00 11.73 97.73 4.45 
aMean of three determinations. 
 
The derivative spectrophotometric method was considered 
accurate for the proposed drugs, presenting a satisfactory 




The results of the robustness are summarized in Table 4. 
The PYZ and RIF content were unaffected by the alteration 
of the methanol concentration used in the sample 
preparation, with RSD values lower than 5% for both drugs. 
This results demonstrate that little variation in the 
proportion of methanol:water used in the preparation of the 
samples did not influence the drug recovery.  
 
Table 4. Effects of the variation of analytical parameters in the 









PYZa 8.12 ± 0.11 101.52 1.35 
RIFa 7.75 ± 0.17 96.84 2.21 




A first-derivative spectrometric method was developed and 
validated for simultaneous determination of PYZ and RIF 
in cubosome formulation. The results of validation showed 
that the analytical method demonstrating to be simple, 
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